Senseonics Holdings (SENS) Free Cash Flow (QoQ) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Senseonics Holdings | 316.18 Mn | 251.85 Mn | 6.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -85.79% |
| Dec 31, 2025 | -4.93% |
| Sep 30, 2025 | -85.50% |
| Jun 30, 2025 | 46.19% |
| Mar 31, 2025 | -32.55% |
| Dec 31, 2024 | 14.73% |
| Sep 30, 2024 | -10.41% |
| Jun 30, 2024 | 35.69% |
| Mar 31, 2024 | -36.64% |
| Dec 31, 2023 | 13.38% |
| Sep 30, 2023 | 3.37% |
| Jun 30, 2023 | 9.56% |
| Mar 31, 2023 | -14.06% |
| Dec 31, 2022 | -19.25% |
| Sep 30, 2022 | -2.61% |
| Jun 30, 2022 | 29.76% |
| Mar 31, 2022 | -72.61% |
| Dec 31, 2021 | 15.39% |
| Sep 30, 2021 | 2.04% |
| Jun 30, 2021 | 12.81% |
| Mar 31, 2021 | -97.25% |
| Dec 31, 2020 | 39.17% |
| Sep 30, 2020 | 18.82% |
| Jun 30, 2020 | 42.60% |
| Mar 31, 2020 | 13.51% |
| Dec 31, 2019 | 7.61% |
| Sep 30, 2019 | -2.62% |
| Jun 30, 2019 | -16.16% |
| Mar 31, 2019 | -31.83% |
| Dec 31, 2018 | 14.94% |
| Sep 30, 2018 | -35.97% |
| Jun 30, 2018 | 2.34% |
| Mar 31, 2018 | -25.56% |
| Dec 31, 2017 | -6.43% |
| Sep 30, 2017 | -20.36% |
| Jun 30, 2017 | -9.52% |
| Mar 31, 2017 | -13.64% |
| Dec 31, 2016 | 2.51% |
| Sep 30, 2016 | -2.32% |
| Jun 30, 2016 | -37.57% |
| Sep 30, 2015 | 98.76% |
| Jun 30, 2015 | -110.81% |
| Mar 31, 2015 | -64,326.52% |
| Dec 31, 2014 | -39.97% |